医学
全身疗法
肝细胞癌
肿瘤科
肝癌
肝细胞癌
内科学
重症监护医学
癌症
乳腺癌
作者
Eric H Bent,Eric Wehrenberg-Klee,Eugene J. Koay,Lipika Goyal,Jennifer Y. Wo
出处
期刊:Journal of The National Comprehensive Cancer Network
日期:2021-05-01
卷期号:19 (5): 567-576
被引量:3
标识
DOI:10.6004/jnccn.2021.7037
摘要
Treatment options in locally advanced hepatocellular carcinoma (HCC) have evolved considerably over the past few years with the recent approval of multiple systemic therapies and significant advances in locoregional therapy. Given the poor prognosis for patients with unresectable HCC, there is significant interest in rationally designed combination therapies. This article reviews the treatment options available to patients with locally advanced HCC and discusses the rationale, ongoing trials, and future prospects for combining locoregional and systemic therapy in both the definitive and neoadjuvant settings.
科研通智能强力驱动
Strongly Powered by AbleSci AI